KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?

D. Rodriguez Abreu; M. C. Garassino; E. Esteban; G. Speranza; E. Felip; M. Domine; M. J. Hochmair; S. F. Powell; S. Y.S. Cheng; H. Bischoff; N. Peled; R. Hui; M. Reck; E. B. Garon; M. Boyer; F. Grossi; R. Jennens; J. Yang; M. C. Pietanza; S. M. Gadgeel

doi:10.1093/annonc/mdy292.086

KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?

D. Rodriguez Abreu, M. C. Garassino, E. Esteban, G. Speranza, E. Felip, M. Domine, M. J. Hochmair, S. F. Powell, S. Y.S. Cheng, H. Bischoff, N. Peled, R. Hui, M. Reck, E. B. Garon, M. Boyer, F. Grossi, R. Jennens, J. Yang, M. C. Pietanza, S. M. Gadgeel

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	viii529-viii530
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy292.086
Publication status	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy292.086

Cite this

Rodriguez Abreu, D., Garassino, M. C., Esteban, E., Speranza, G., Felip, E., Domine, M., Hochmair, M. J., Powell, S. F., Cheng, S. Y. S., Bischoff, H., Peled, N., Hui, R., Reck, M., Garon, E. B., Boyer, M., Grossi, F., Jennens, R., Yang, J., Pietanza, M. C., & Gadgeel, S. M. (2018). KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes? Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii529-viii530. https://doi.org/10.1093/annonc/mdy292.086

KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC : Does choice of platinum affect outcomes? / Rodriguez Abreu, D.; Garassino, M. C.; Esteban, E.; Speranza, G.; Felip, E.; Domine, M.; Hochmair, M. J.; Powell, S. F.; Cheng, S. Y.S.; Bischoff, H.; Peled, N.; Hui, R.; Reck, M.; Garon, E. B.; Boyer, M.; Grossi, F.; Jennens, R.; Yang, J.; Pietanza, M. C.; Gadgeel, S. M.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii529-viii530.

Research output: Contribution to journal › Article › peer-review

Rodriguez Abreu, D, Garassino, MC, Esteban, E, Speranza, G, Felip, E, Domine, M, Hochmair, MJ, Powell, SF, Cheng, SYS, Bischoff, H, Peled, N, Hui, R, Reck, M, Garon, EB, Boyer, M, Grossi, F, Jennens, R, Yang, J, Pietanza, MC & Gadgeel, SM 2018, 'KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii529-viii530. https://doi.org/10.1093/annonc/mdy292.086

Rodriguez Abreu D, Garassino MC, Esteban E, Speranza G, Felip E, Domine M et al. KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes? Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii529-viii530. https://doi.org/10.1093/annonc/mdy292.086

Rodriguez Abreu, D. ; Garassino, M. C. ; Esteban, E. ; Speranza, G. ; Felip, E. ; Domine, M. ; Hochmair, M. J. ; Powell, S. F. ; Cheng, S. Y.S. ; Bischoff, H. ; Peled, N. ; Hui, R. ; Reck, M. ; Garon, E. B. ; Boyer, M. ; Grossi, F. ; Jennens, R. ; Yang, J. ; Pietanza, M. C. ; Gadgeel, S. M. / KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC : Does choice of platinum affect outcomes?. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii529-viii530.

@article{2bec0e2bd61049b987fdf30b37198791,

title = "KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?",

author = "{Rodriguez Abreu}, D. and Garassino, {M. C.} and E. Esteban and G. Speranza and E. Felip and M. Domine and Hochmair, {M. J.} and Powell, {S. F.} and Cheng, {S. Y.S.} and H. Bischoff and N. Peled and R. Hui and M. Reck and Garon, {E. B.} and M. Boyer and F. Grossi and R. Jennens and J. Yang and Pietanza, {M. C.} and Gadgeel, {S. M.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy292.086",

language = "English",

volume = "29",

pages = "viii529--viii530",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

}

TY - JOUR

T1 - KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC

T2 - Does choice of platinum affect outcomes?

AU - Rodriguez Abreu, D.

AU - Garassino, M. C.

AU - Esteban, E.

AU - Speranza, G.

AU - Felip, E.

AU - Domine, M.

AU - Hochmair, M. J.

AU - Powell, S. F.

AU - Cheng, S. Y.S.

AU - Bischoff, H.

AU - Peled, N.

AU - Hui, R.

AU - Reck, M.

AU - Garon, E. B.

AU - Boyer, M.

AU - Grossi, F.

AU - Jennens, R.

AU - Yang, J.

AU - Pietanza, M. C.

AU - Gadgeel, S. M.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85073702356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073702356&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy292.086

DO - 10.1093/annonc/mdy292.086

M3 - Article

C2 - 32137375

VL - 29

SP - viii529-viii530

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -